Bacterial meningitis: Diagnosis and treatment

Current Neurology and Neuroscience Reports

Volumn 3, Issue 6, 2003, Pages 461-469

  Snyder, Russell D ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTITHROMBIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; DOXYCYCLINE; ETHAMBUTOL; GENTAMICIN; GLUCOCORTICOID; HAEMOPHILUS INFLUENZAE VACCINE; HEPARIN; ISONIAZID; MANNITOL; PENICILLIN G; PNEUMOCOCCUS POLYSACCHARIDE; PREDNISONE; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTHRAX; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL MENINGITIS; BLOOD ANALYSIS; BRAIN ABSCESS; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN SURGERY; BRAIN VENTRICLE DILATATION; CEREBROSPINAL FLUID ANALYSIS; CHILDHOOD DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG MEGADOSE; EPIDEMIC MENINGITIS; FATALITY; FEVER; HAEMOPHILUS INFLUENZAE; HEADACHE; HEARING LOSS; HUMAN; HYDROCEPHALUS; HYPERVENTILATION; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; LYME DISEASE; NEISSERIA MENINGITIDIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SEIZURE; STAPHYLOCOCCUS; TUBERCULOUS MENINGITIS; VASOPRESSIN RELEASE; VOMITING; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; HUMANS; MENINGITIS, BACTERIAL;

EID: 1542599102     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0048-3     Document Type: Review

References (50)

1. Schuchat A, Robinson K, Wenger JD, et al.: Bacterial meningitis in the United States in 1995. N Engl J Med 1997, 337:970-976.
2. Kastenbauer S, Pfister HW: Pneumococcal meningitis in adults. Spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003, 126:1015-1025.
3. Simon RP, Beckman JS: Why pus is bad for the brain. Neurology 2002, 58:167-168.
4. Rodriguez-Nunez A, Rodriquez-Garcia J, Camina F, et al.: Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis. Brain Dev 2003, 25:102-106.
5. vanFurth AM, Roord JJ, vanFurth R: Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immunol 1996, 64:4883-4890.
6. Scheld WM, Koedel U, Nathan B, et al.: Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002, 186:S225-S233.
7. Tunkel AR, Scheld WM: Corticosteroids for everyone with meningitis? N Engl J Med 2002, 347:1613-1614.
8. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
9. Heyderman RS, Klein NJ: Emergency management of meningitis. J R Soc Med 2000, 93:225-229.
10. Kilpi T, Anttila M, Kallio MJT, et al.: Length of prediagnostic history related to the course and sequelae of childhood bacterial meningitis. Pediatr Infect Dis J 1993, 12:184-188.
11. Palacio S, Hart RG, Vollmer DG, et al.: Late-developing cerebral arteropathy after pyogenic meningitis. Arch Neurol 2003, 60:431-433.
12. Heyderman RS, Lambert HP, O'Sullivan I, et al.: Early management of suspected bacterial meningitis and meningococcal septicaemia in adults. J Infect 2003, 46:75-77.
13. Quagliarello VJ, Scheld WM: Treatment of bacterial meningitis. N Engl J Med 1997, 336:708-716.
14. Negrini B, Kelleher JJ, Wald ER: Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 2000, 105:316-319.
15. Saravolatz LD, Manzor O, VanderVelde N, et al.: Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitis. Clin Infect Dis 2003, 36:40-45.
16. Runge VM, Wells JW, Williams NM, et al.: Detectability of early brain meningitis with magnetic resonance imaging. Invest Radiol 1995, 30:484-495.
17. Teixeira J, Zimmerman RA, Haselgrove JC, et al.: Diffusion imaging in pediatric central nervous system infections. Neuroradiol 2001, 43:1031-1039.
18. Hasbun R, Abrahams J, Jekel J, et al.: Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001, 345:1727-1733.
19. Hansson LO, Axelsson G, Linne T, et al.: Serum C-reactive protein in the differential diagnosis of acute meningitis. Scand J Infect Dis 1993, 25:625-630.
20. Coyle PK: Glucocorticoids in central nervous system bacterial infection. Arch Neurol 1999, 56:796-801.
21. The choice of antibacterial drugs: Med Lett Drugs Ther 2001, 43:69-78.
22. Peltola H: Controversies in the management of childhood meningitis. J Med Microbiol 1997, 46:901-902.
23. Natsch S, Kullberg BJ, vanderMeer JW, et al.: Delay in administering the first does of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Infect Dis 1998, 17:661-684.
24. de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2003, 348:955-956.
25. Oostenbrink R, Moons KG, Derksen-Lubsen G, et al.: Early prediction of neurological sequelae or death after bacterial meningitis. Acta Paediat 2002, 91:391-398.
26. Oostenbrink R, Maas M, Moons KG, et al.: Sequelae after bacterial meningitis in childhood. Scand J Infect Dis 2002, 34:379-382.
27. Bedford H, deLouvois J, Halket S, et al.: Meningitis in infancy in England and Wales: follow up at 5 years. BMJ 2001, 323:533-536.
28. Koomen I, Grobbee DE, Jennekens-Schinkel A, et al.: Parental perception of educational, behavioural and general health problems in school-age survivors of bacterial meningitis. Acta Paediat 2003, 92:177-185.
29. Halperin JJ: Nervous system Lyme disease. Infect Med 2000, 17:556-560.
30. Tuerlinckx D, Bodart E, Garrino MG, et al.: Clinical data and cerebrospinal fluid findings in Lyme meningitis versus aseptic meningitis. Eur J Pediatr 2003, 162:150-153.
31. Lanska DJ: Anthrax meningoencephalitis. Neurology 2002, 59:327-334.
32. Meyer MA: Neurologic complications of anthrax. Arch Neurol 2003, 60:483-488.
33. Roos KL: Medusa's head in bloody CSF. Neurology 2002, 59:300-301.
34. DeBiasi RL, Tyler KL: Polymerase chain reaction in the diagnosis and management of central nervous system infections. Arch Neurol 1999, 56:1215-1219.
35. Roos KL: Seizure activity is an expected complication of bacterial meningitis and should be treated rapidly and aggressively. In Meningitis: 100 Maxims. Edited by Devinsky O. London: Arnold; 1996:76-77.
36. Sigurdardottier B, Bjornsson OM, Jonsdottir KE, et al.: Acute bacterial meningitis in adults: a 20-year overview. Arch Intern Med 1997, 157:425-430.
37. Baraff LJ, Lee SI, Schriger DL: Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 1995,
38. Moller K, Larsen FS, Bie P, et al.: The syndrome of inappropriate secretion of antidiuretic hormone and fluid restriction in meningitis - how strong is the evidence? Scand J Infect Dis 2001, 33:13-26.
39. Fortnum H: Hearing impairment after bacterial meningitis: a review. Arch Dis Child 1992, 67:1128-1133.
40. Woolley AL, Kirk KA, Neumann AM, et al.: Risk factors for hearing loss from meningitis in children - The Children's Hospital experience. Arch Otolaryngol Head Neck Surg 1999, 125:509-514.
41. Jiang ZD: Outcome of brain stem auditory electrophysiology in children who survive purulent meningitis. Ann Otol Rhinol Laryngol 1999, 108:429-434.
42. Dichgans M, Jager L, Mayer T, et al.: Bacterial meningitis in adults: demonstration of inner ear involvement using high-resolution MRI. Neurology 1999, 52:1003-1009.
43. Kaplan SL, Smith EO, Wills C, et al.: Association between preadmission oral antibiotic therapy and cerebrospinal fluid findings and sequelae caused by Haemophilus influenzae type b meningitis. Pediatr Infect Dis 1986, 5:626-632.
44. Radetsky M: Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 1992, 11:694-698.
45. Levi M, ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592.
46. Whitney CG, Farley MM, Hadler J, et al.: Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348:1737-1746.
47. Jackson LA, Neuzil KM, Yu O, et al.: Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003, 348:1747-1755.
48. Perez CO: Dexamethasone effect on the inflammatory response of the central nervous system in bacterial meningitis. Curr Ther Res 1996, 57, Suppl. A:52-56.
49. de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347:1549-1556.
50. Small PM, Fujiwara PI: Management of tuberculosis in the United States. N Engl J Med 2001, 345:189-200.